# ClinicalTrials.gov record NCT00759772

> PeptideScanner retained ClinicalTrials.gov record NCT00759772 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-05-11, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct00759772-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2017-05-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00759772-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00759772-teriparatide-v1.json
- Content SHA-256: `f45015968071bb8955de199b0184fc56c6390e537a696ceb93543be7de01bb52`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00759772 ([`ctg-observation-nct00759772-2017-05-11-3a7458b69f75`](#source-ctg-observation-nct00759772-2017-05-11-3a7458b69f75))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00759772 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-05-11, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00759772-2017-05-11-3a7458b69f75`](#source-ctg-observation-nct00759772-2017-05-11-3a7458b69f75))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00759772 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-05-11, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00759772-2017-05-11-3a7458b69f75`](#source-ctg-observation-nct00759772-2017-05-11-3a7458b69f75))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00759772-2017-05-11-3a7458b69f75`](#source-ctg-observation-nct00759772-2017-05-11-3a7458b69f75))

## Sources

<a id="source-ctg-observation-nct00759772-2017-05-11-3a7458b69f75"></a>
- **ClinicalTrials.gov record NCT00759772 · retained source version 2017-05-11:3a7458b69f75b9a2147dd422656ad85f7f4e90c2a7f9404c27f979b9f6df1180** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00759772) (`ctg-observation-nct00759772-2017-05-11-3a7458b69f75`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00759772." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00759772-teriparatide-v1.json SHA-256: f45015968071bb8955de199b0184fc56c6390e537a696ceb93543be7de01bb52.